跳至主要内容
临床试验/CTRI/2026/03/106796
CTRI/2026/03/106796尚未招募2 期

Cardiometabolic and hormonal profile in patients of polycystic ovarian syndrome supplemented with calcium and vitamin-D to conventional myo-inositol treatment: a randomized controlled trial.

Department of Pharmacology1 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2026年4月2日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
114
试验地点
1

研究概览

简要总结

PCOS is a common endocrine disorder associated with reproductive, hormonal and metabolic abnormalities. Vitamin-D deficiency is common in these patients and along with calcium imbalance, may worsen metabolic and reproductive dysfunction. Insulin resistance is also a common factor in the etiology of PCOS. Conventional therapy for PCOS includes metformin or myoinositol. Myoinositol improves Insulin sensitivity and hormonal balance in PCOS. Therefore, adding calcium & vitamin-D to myoinositol therapy may provide additional benefits in improving cardiometabolic and hormonal profiles in PCOS.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Patients of 18 to 45 years age group.
  • Newly diagnosed PCOS patients as per Rotterdam Criteria.
  • Patients willing to give Consent.

排除标准

  • Patient aged less than 18 years or greater than 45 years.
  • Participants who have received vitamin supplementation, insulin sensitizers or any other hormonal treatment within the last 3months.
  • Patients with known adrenal disorders.
  • Patients with thyroid dysfunction.
  • Patients with a history of long-standing Diabetes Mellitus.
  • Patients with severe debilitating disorders.
  • Patient unwilling to provide voluntary informed consent for participation.
  • Pregnant women and lactating mothers.

研究者

申办方类型
Other []
责任方
Principal Investigator
主要研究者

Anjali Khitoliya

LLRM Medical College, Meerut

研究点 (1)

Loading locations...

相似试验